Checkpoint inhibition: a new beginning for urothelial cancer

Tracy L. Rose, Matthew I. Milowsky

Research output: Contribution to journalComment/debate

  • 1 Citations
LanguageEnglish (US)
Pages160-161
Number of pages2
JournalThe Lancet Oncology
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Checkpoint inhibition : a new beginning for urothelial cancer. / Rose, Tracy L.; Milowsky, Matthew I.

In: The Lancet Oncology, Vol. 18, No. 2, 01.02.2017, p. 160-161.

Research output: Contribution to journalComment/debate

@article{4e0f09ec71a94ef8a8cd4dacfa810572,
title = "Checkpoint inhibition: a new beginning for urothelial cancer",
author = "Rose, {Tracy L.} and Milowsky, {Matthew I.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/S1470-2045(16)30675-1",
language = "English (US)",
volume = "18",
pages = "160--161",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Checkpoint inhibition

T2 - The Lancet Oncology

AU - Rose,Tracy L.

AU - Milowsky,Matthew I.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85009267017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009267017&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(16)30675-1

DO - 10.1016/S1470-2045(16)30675-1

M3 - Comment/debate

VL - 18

SP - 160

EP - 161

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 2

ER -